Long-term effects of SARS-CoV-2 on the brain

NewsGuard 100/100 Score

More profoundly than previously believed, the virus that causes COVID-19, SARS-CoV-2, can impact the brain for months after infection. The findings were presented at Neuroscience 2022, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health.

"Long COVID," which includes the neurological fallout (a.k.a. sequelae) of a COVID-19 infection, can damage the central nervous system long after the acute symptoms of the virus have passed. Estimates report that one in five to one half of all adults are affected by at least one long COVID symptom, which includes ailments to mood and concentration. Scientists are still learning how the virus changes the brain, but it's becoming increasingly clear that the long-term effects are wide-ranging across age groups.

Today's new findings show that:

  • Using fMRI imaging, scientists found that the sensorimotor brain regions of children who contracted COVID-19 months ago now showed a higher demand for resources. (Silvia Hidalgo-Tobon, UAM-Hospital Infantil de Mexico Federico Gomez)
  • To mimic SARS-CoV-2's impacts, scientists triggered inflammation in a mouse model via toll-like receptor (TLR) 7. Eight weeks later, they found hippocampal impairment in both sexes and decreased fear conditioning in males. (Natalie C. Tronson, University of Michigan)
  • Scientists found that roughly one-fourth of adults who had mild COVID-19 four months prior were left with deficits in their visuoconstructive abilities. (Marco Aurelio Romano-Silva, Universidade Federal De Minas Gerais)

This isn't the first time that a flu-like viral infection has been linked to an increased risk for dementia. But one of the most important aspects of this work is the magnitude of people potentially affected by this -; millions upon millions."

Robyn Klein, The Robert E. and Louise F. Dunn Distinguished Professor of Medical Sciences, director of the Center for Neuroimmunology & Neuroinfectious Diseases, professor of medicine, pathology & immunology, and neurosciences at Washington University School of Medicine, and moderator

"We need to move on to alternative hypotheses for these neurologic diseases; we also need to inform the public and physicians that this is a real illness and that they should be proactive in addressing it."

This research was supported by national funding agencies including the National Institutes of Health and private funding organizations. Find out more about COVID-19 and cognitive functioning on BrainFacts.org.


  1. Paul Elkins Paul Elkins United States says:

    It's alarming at how many patients continue to suffer with neuro and cognitive impacts of Covid. It's one of the most prevalent symptoms of PASC. However, it occurs frequently in cases even outside of PASC. There is also alarming data showing significantly elevated risk in a new dementia diagnosises following a Covid infection.  There is data that points to a potential therapeutic (the mast cell stabilizer, cromolyn) which appears to help with brain inflammation.  Here is a pertinent study on the subject: link.springer.com/.../s12035-016-9720-x#Abs1

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Climate change may negatively affect the health of people with brain conditions